NxGen Brands Inc. (NXGB)
OTCMKTS · Delayed Price · Currency is USD
0.0064
0.00 (0.00%)
At close: Aug 5, 2025
NxGen Brands Market Cap
NxGen Brands has a market cap or net worth of $2.14 million as of August 8, 2025. Its market cap has increased by 69.30% in one year.
Market Cap
2.14M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since April 5, 2016, NxGen Brands's market cap has increased from 180.03K to 2.14M, an increase of 1,089.39%. That is a compound annual growth rate of 30.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 2.14M | 3,015,828.17% |
| Dec 23, 2024 | 71.00 | -99.98% |
| Dec 29, 2023 | 397.40K | -34.99% |
| Dec 29, 2022 | 611.31K | -83.01% |
| Dec 31, 2021 | 3.60M | 74.41% |
| Dec 31, 2020 | 2.06M | 111.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |